Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia

J. Meyer, C. W. Lentz, J. C. Stothert, L. D. Traber, David Herndon, D. L. Traber

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Objective: To investigate the effects of N(ω)-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on hemodynamics, gas exchange and oxygen transport in an ovine model of hyperdynamic sepsis. Design: Prospective, nonrandomized, controlled study, with repeated measurements. Setting: University research laboratory. Subjects: Twenty healthy adult sheep (weighing 20 to 45 kg) were divided into two groups of 12 treated sheep and eight control sheep and studied. Interventions: Twenty awake, chronically instrumented sheep received a continuous infusion of endotoxin (10 ng/kg/min) over 48 hrs. Twenty-four hours after the start of the endotoxin infusion, 12 sheep (treatment group) received a bolus of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester (25 mg/kg), while the other eight animals (control group) received the carrier (0.9% NaCl). Measurements and Main Results: Twenty-four hours after the start of the endotoxin infusion, both groups exhibited a hyperdynamic state with increased cardiac indices, decreased systemic vascular resistance indices, impaired oxygenation, and increased pulmonary shunt fractions. In both groups, oxygen delivery was significantly increased, while oxygen consumption remained virtually unchanged, resulting in a decreased oxygen extraction ratio. In the control group, the significant alterations in systemic hemodynamics, lung function and oxygen transport persisted for the remainder of the study. Administration of N(ω)-nitro-L-arginine methyl ester normalized cardiac index and systemic vascular resistance index, increased mean arterial blood pressure, and decreased heart rate. Although oxygen delivery significantly decreased after administration of N(ω)-nitro-L-arginine methyl ester, oxygen consumption did not change, resulting in a normalization of oxygen extraction ratio. Despite a significant reduction of pulmonary shunt fraction, oxygenation did not improve. Pulmonary arterial pressure and pulmonary vascular resistance index showed a peak 2 hrs after administration of the nitric oxide synthesis inhibitor and then tended to decrease. In contrast, the effects of N(ω)-nitro-L-arginine methyl ester on the systemic circulation persisted for the remainder of the study. Conclusions: The data support the assumption that augmented nitric oxide production is a major cause of the hemodynamic alterations seen in hyperdynamic endotoxemia. Administration of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester normalized the endotoxin-induced hyperdynamic state, but did not impair oxygen consumption, indicating adequate tissue perfusion of metabolically active organs. Inhibition of nitric oxide synthesis may be a therapeutic option in the treatment of hyperdynamic septic patients when conventional therapy fails to maintain a minimum of cardiovascular performance.

Original languageEnglish (US)
Pages (from-to)306-312
Number of pages7
JournalCritical Care Medicine
Volume22
Issue number2
StatePublished - 1994

Fingerprint

Endotoxemia
Sheep
Nitric Oxide
Oxygen
Endotoxins
Oxygen Consumption
Vascular Resistance
Lung
Arterial Pressure
Hemodynamics
Control Groups
Therapeutics
arginine methyl ester
Sepsis
Healthy Volunteers
Perfusion
Heart Rate
Gases
Research

Keywords

  • cardiac output
  • critical illness
  • endothelium-derived relaxing factor
  • endotoxin
  • hemodynamics
  • hyperdynamic
  • nitric oxide
  • oxygen consumption
  • sepsis
  • vascular resistance

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Meyer, J., Lentz, C. W., Stothert, J. C., Traber, L. D., Herndon, D., & Traber, D. L. (1994). Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Critical Care Medicine, 22(2), 306-312.

Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. / Meyer, J.; Lentz, C. W.; Stothert, J. C.; Traber, L. D.; Herndon, David; Traber, D. L.

In: Critical Care Medicine, Vol. 22, No. 2, 1994, p. 306-312.

Research output: Contribution to journalArticle

Meyer, J, Lentz, CW, Stothert, JC, Traber, LD, Herndon, D & Traber, DL 1994, 'Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia', Critical Care Medicine, vol. 22, no. 2, pp. 306-312.
Meyer J, Lentz CW, Stothert JC, Traber LD, Herndon D, Traber DL. Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Critical Care Medicine. 1994;22(2):306-312.
Meyer, J. ; Lentz, C. W. ; Stothert, J. C. ; Traber, L. D. ; Herndon, David ; Traber, D. L. / Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. In: Critical Care Medicine. 1994 ; Vol. 22, No. 2. pp. 306-312.
@article{d0a5afcda9414c84989cdfcf1f2946fa,
title = "Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia",
abstract = "Objective: To investigate the effects of N(ω)-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on hemodynamics, gas exchange and oxygen transport in an ovine model of hyperdynamic sepsis. Design: Prospective, nonrandomized, controlled study, with repeated measurements. Setting: University research laboratory. Subjects: Twenty healthy adult sheep (weighing 20 to 45 kg) were divided into two groups of 12 treated sheep and eight control sheep and studied. Interventions: Twenty awake, chronically instrumented sheep received a continuous infusion of endotoxin (10 ng/kg/min) over 48 hrs. Twenty-four hours after the start of the endotoxin infusion, 12 sheep (treatment group) received a bolus of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester (25 mg/kg), while the other eight animals (control group) received the carrier (0.9{\%} NaCl). Measurements and Main Results: Twenty-four hours after the start of the endotoxin infusion, both groups exhibited a hyperdynamic state with increased cardiac indices, decreased systemic vascular resistance indices, impaired oxygenation, and increased pulmonary shunt fractions. In both groups, oxygen delivery was significantly increased, while oxygen consumption remained virtually unchanged, resulting in a decreased oxygen extraction ratio. In the control group, the significant alterations in systemic hemodynamics, lung function and oxygen transport persisted for the remainder of the study. Administration of N(ω)-nitro-L-arginine methyl ester normalized cardiac index and systemic vascular resistance index, increased mean arterial blood pressure, and decreased heart rate. Although oxygen delivery significantly decreased after administration of N(ω)-nitro-L-arginine methyl ester, oxygen consumption did not change, resulting in a normalization of oxygen extraction ratio. Despite a significant reduction of pulmonary shunt fraction, oxygenation did not improve. Pulmonary arterial pressure and pulmonary vascular resistance index showed a peak 2 hrs after administration of the nitric oxide synthesis inhibitor and then tended to decrease. In contrast, the effects of N(ω)-nitro-L-arginine methyl ester on the systemic circulation persisted for the remainder of the study. Conclusions: The data support the assumption that augmented nitric oxide production is a major cause of the hemodynamic alterations seen in hyperdynamic endotoxemia. Administration of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester normalized the endotoxin-induced hyperdynamic state, but did not impair oxygen consumption, indicating adequate tissue perfusion of metabolically active organs. Inhibition of nitric oxide synthesis may be a therapeutic option in the treatment of hyperdynamic septic patients when conventional therapy fails to maintain a minimum of cardiovascular performance.",
keywords = "cardiac output, critical illness, endothelium-derived relaxing factor, endotoxin, hemodynamics, hyperdynamic, nitric oxide, oxygen consumption, sepsis, vascular resistance",
author = "J. Meyer and Lentz, {C. W.} and Stothert, {J. C.} and Traber, {L. D.} and David Herndon and Traber, {D. L.}",
year = "1994",
language = "English (US)",
volume = "22",
pages = "306--312",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia

AU - Meyer, J.

AU - Lentz, C. W.

AU - Stothert, J. C.

AU - Traber, L. D.

AU - Herndon, David

AU - Traber, D. L.

PY - 1994

Y1 - 1994

N2 - Objective: To investigate the effects of N(ω)-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on hemodynamics, gas exchange and oxygen transport in an ovine model of hyperdynamic sepsis. Design: Prospective, nonrandomized, controlled study, with repeated measurements. Setting: University research laboratory. Subjects: Twenty healthy adult sheep (weighing 20 to 45 kg) were divided into two groups of 12 treated sheep and eight control sheep and studied. Interventions: Twenty awake, chronically instrumented sheep received a continuous infusion of endotoxin (10 ng/kg/min) over 48 hrs. Twenty-four hours after the start of the endotoxin infusion, 12 sheep (treatment group) received a bolus of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester (25 mg/kg), while the other eight animals (control group) received the carrier (0.9% NaCl). Measurements and Main Results: Twenty-four hours after the start of the endotoxin infusion, both groups exhibited a hyperdynamic state with increased cardiac indices, decreased systemic vascular resistance indices, impaired oxygenation, and increased pulmonary shunt fractions. In both groups, oxygen delivery was significantly increased, while oxygen consumption remained virtually unchanged, resulting in a decreased oxygen extraction ratio. In the control group, the significant alterations in systemic hemodynamics, lung function and oxygen transport persisted for the remainder of the study. Administration of N(ω)-nitro-L-arginine methyl ester normalized cardiac index and systemic vascular resistance index, increased mean arterial blood pressure, and decreased heart rate. Although oxygen delivery significantly decreased after administration of N(ω)-nitro-L-arginine methyl ester, oxygen consumption did not change, resulting in a normalization of oxygen extraction ratio. Despite a significant reduction of pulmonary shunt fraction, oxygenation did not improve. Pulmonary arterial pressure and pulmonary vascular resistance index showed a peak 2 hrs after administration of the nitric oxide synthesis inhibitor and then tended to decrease. In contrast, the effects of N(ω)-nitro-L-arginine methyl ester on the systemic circulation persisted for the remainder of the study. Conclusions: The data support the assumption that augmented nitric oxide production is a major cause of the hemodynamic alterations seen in hyperdynamic endotoxemia. Administration of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester normalized the endotoxin-induced hyperdynamic state, but did not impair oxygen consumption, indicating adequate tissue perfusion of metabolically active organs. Inhibition of nitric oxide synthesis may be a therapeutic option in the treatment of hyperdynamic septic patients when conventional therapy fails to maintain a minimum of cardiovascular performance.

AB - Objective: To investigate the effects of N(ω)-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on hemodynamics, gas exchange and oxygen transport in an ovine model of hyperdynamic sepsis. Design: Prospective, nonrandomized, controlled study, with repeated measurements. Setting: University research laboratory. Subjects: Twenty healthy adult sheep (weighing 20 to 45 kg) were divided into two groups of 12 treated sheep and eight control sheep and studied. Interventions: Twenty awake, chronically instrumented sheep received a continuous infusion of endotoxin (10 ng/kg/min) over 48 hrs. Twenty-four hours after the start of the endotoxin infusion, 12 sheep (treatment group) received a bolus of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester (25 mg/kg), while the other eight animals (control group) received the carrier (0.9% NaCl). Measurements and Main Results: Twenty-four hours after the start of the endotoxin infusion, both groups exhibited a hyperdynamic state with increased cardiac indices, decreased systemic vascular resistance indices, impaired oxygenation, and increased pulmonary shunt fractions. In both groups, oxygen delivery was significantly increased, while oxygen consumption remained virtually unchanged, resulting in a decreased oxygen extraction ratio. In the control group, the significant alterations in systemic hemodynamics, lung function and oxygen transport persisted for the remainder of the study. Administration of N(ω)-nitro-L-arginine methyl ester normalized cardiac index and systemic vascular resistance index, increased mean arterial blood pressure, and decreased heart rate. Although oxygen delivery significantly decreased after administration of N(ω)-nitro-L-arginine methyl ester, oxygen consumption did not change, resulting in a normalization of oxygen extraction ratio. Despite a significant reduction of pulmonary shunt fraction, oxygenation did not improve. Pulmonary arterial pressure and pulmonary vascular resistance index showed a peak 2 hrs after administration of the nitric oxide synthesis inhibitor and then tended to decrease. In contrast, the effects of N(ω)-nitro-L-arginine methyl ester on the systemic circulation persisted for the remainder of the study. Conclusions: The data support the assumption that augmented nitric oxide production is a major cause of the hemodynamic alterations seen in hyperdynamic endotoxemia. Administration of the nitric oxide synthesis inhibitor N(ω)-nitro-L-arginine methyl ester normalized the endotoxin-induced hyperdynamic state, but did not impair oxygen consumption, indicating adequate tissue perfusion of metabolically active organs. Inhibition of nitric oxide synthesis may be a therapeutic option in the treatment of hyperdynamic septic patients when conventional therapy fails to maintain a minimum of cardiovascular performance.

KW - cardiac output

KW - critical illness

KW - endothelium-derived relaxing factor

KW - endotoxin

KW - hemodynamics

KW - hyperdynamic

KW - nitric oxide

KW - oxygen consumption

KW - sepsis

KW - vascular resistance

UR - http://www.scopus.com/inward/record.url?scp=0028044665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028044665&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 306

EP - 312

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 2

ER -